We have read with great interest the recent multicenter Open Radial Artery Study1 (ORAS), which explores the efficacy of patent hemostasis in preventing early and late radial artery occlusion (RAO) in patients who undergo coronary diagnostic or interventional procedures through transradial artery access (TRA).